French Pharmacovigilance Public System and COVID-19 Pandemic.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 405, doi. 10.1007/s40264-020-01034-y
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 4
Results: 15
1
2
The DIANA Study: Continued Access to Darunavir/Ritonavir (DRV/r) and Long-Term Safety Follow-Up in HIV-1-Infected Pediatric Patients Aged 3 to < 18 Years.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 439, doi. 10.1007/s40264-020-01032-0
- By:
- Publication type:
- Article
3
Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
4
Correction to: 19th ISoP Annual Meeting "New Opportunities for New Generations" Bogotá, Colombia, 26–29 October, 2019.
- Published in:
- 2021
- Publication type:
- Correction Notice
5
ISoP Fellowships: Recognising and Promoting Leaders in Pharmacovigilance.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
6
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Safety Consequences of Off-Label Drugs Used for COVID-19.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 399, doi. 10.1007/s40264-021-01056-0
- By:
- Publication type:
- Article
8
Comment on: "Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance".
- Published in:
- 2021
- By:
- Publication type:
- Letter
9
Authors' Reply to Robert P. Giugliano and Colleagues' Comment on: "Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance".
- Published in:
- 2021
- By:
- Publication type:
- Letter
10
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
- Published in:
- 2021
- By:
- Publication type:
- journal article
11
Risk Management for the 21st Century: Current Status and Future Needs.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 409, doi. 10.1007/s40264-020-01033-z
- By:
- Publication type:
- Article
12
Communicating About Risks and Safe Use of Medicines: Priya Bahri, editor. Adis, 2020. Hardcover ISBN 978-981-15-3012-8, eBook ISBN 978-981-15-3013-5.
- Published in:
- 2021
- By:
- Publication type:
- Book Review
13
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 467, doi. 10.1007/s40264-020-01041-z
- By:
- Publication type:
- Article
14
Evaluation of the Risk of Inflammatory Bowel Disease after the HPV Vaccination in Primary Care in Spain: A Time-Varying Cohort Analysis of Around 390,000 Girls.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 455, doi. 10.1007/s40264-020-01040-0
- By:
- Publication type:
- Article
15
Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature.
- Published in:
- Drug Safety, 2021, v. 44, n. 4, p. 421, doi. 10.1007/s40264-020-01038-8
- By:
- Publication type:
- Article